These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10936242)

  • 1. In vitro and in vivo inhibition of anti-gal secreting cells.
    Xu Y; Ryan D; Wu C; Kiessling L; Xu J; Morgan P; Vitetta E; White-Scharf ME; Thall AD
    Transplant Proc; 2000 Aug; 32(5):856. PubMed ID: 10936242
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
    Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
    Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of B cell/plasma cell depletion or suppression on anti-Gal antibody in the baboon.
    Basker M; Alwayn IP; Treter S; Harper D; Buhler L; Andrews D; Thall A; Lambrigts D; Awwad M; White-Scharf M; Sachs DH; Cooper DK
    Transplant Proc; 2000 Aug; 32(5):1009. PubMed ID: 10936323
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice.
    Flavell DJ; Noss A; Pulford KA; Ling N; Flavell SU
    Cancer Res; 1997 Nov; 57(21):4824-9. PubMed ID: 9354445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of CD22, a B-cell restricted molecule.
    Moyron-Quiroz JE; Partida-Sánchez S; Donís-Hernández R; Sandoval-Montes C; Santos-Argumedo L
    Scand J Immunol; 2002 Apr; 55(4):343-51. PubMed ID: 11967115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.
    French RR; Penney CA; Browning AC; Stirpe F; George AJ; Glennie MJ
    Br J Cancer; 1995 May; 71(5):986-94. PubMed ID: 7734325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.
    Donís-Hernández FR; Parkhouse RM; Santos-Argumedo L
    Eur J Immunol; 2001 Apr; 31(4):1261-7. PubMed ID: 11298353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenotyping primitive plasma cells.
    Joshua D; Pope B; Brown R; Brown L; Murray A; Gibson J
    Br J Haematol; 2002 Apr; 117(1):252-3. PubMed ID: 11918567
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?
    Savarino A; Bottarel F; Malavasi F; Dianzani U
    AIDS; 2000 Jun; 14(9):1079-89. PubMed ID: 10894271
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the immunomodulatory mechanisms of photochemotherapy in transplantation.
    Legitimo A; Consolini R; Di Stefano R; Bencivelli W; Calleri A; Mosca F
    Transplant Proc; 2001 May; 33(3):2266-8. PubMed ID: 11377523
    [No Abstract]   [Full Text] [Related]  

  • 12. Siglecs in the immune system.
    Crocker PR; Varki A
    Immunology; 2001 Jun; 103(2):137-45. PubMed ID: 11412300
    [No Abstract]   [Full Text] [Related]  

  • 13. CD38 in hematopoietic malignancies.
    Konopleva M; Rissling I; Andreeff M
    Chem Immunol; 2000; 75():189-206. PubMed ID: 10851785
    [No Abstract]   [Full Text] [Related]  

  • 14. IgG1 production by sIgD+ splenic B cells and peritoneal B-1 cells in response to IL-5 and CD38 ligation.
    Yasue T; Baba M; Mori S; Mizoguchi C; Uehara S; Takatsu K
    Int Immunol; 1999 Jun; 11(6):915-23. PubMed ID: 10360965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell inhibitory receptors and autoimmunity.
    Pritchard NR; Smith KG
    Immunology; 2003 Mar; 108(3):263-73. PubMed ID: 12603592
    [No Abstract]   [Full Text] [Related]  

  • 16. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.
    Hokazono Y; Adachi T; Wabl M; Tada N; Amagasa T; Tsubata T
    J Immunol; 2003 Aug; 171(4):1835-43. PubMed ID: 12902484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independently ligating CD38 and Fc gammaRIIB relays a dominant negative signal to B cells.
    Oliver AM; Grimaldi JC; Howard MC; Kearney JF
    Hybridoma; 1999 Apr; 18(2):113-9. PubMed ID: 10380010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD157 and CD38 antigens on human myeloid leukaemia cells: a similar pattern of modulation with differentiating inducers.
    Anani L; Coffre C; Binet C; Degenne M; Domenech J; Hérault O
    Acta Haematol; 2001; 105(4):249-51. PubMed ID: 11528102
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.
    Ikehata F; Satoh J; Nata K; Tohgo A; Nakazawa T; Kato I; Kobayashi S; Akiyama T; Takasawa S; Toyota T; Okamoto H
    J Clin Invest; 1998 Jul; 102(2):395-401. PubMed ID: 9664081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.